Atlanta Braves Holdings, Inc. (BATRA) officer discloses RSU vesting and tax sale

Rhea-AI Filing Summary

Atlanta Braves Holdings, Inc. reported insider activity by its EVP, Business. On December 11, 2025, restricted stock units converted into 11,142 shares of Series C Common Stock at an exercise price of $0, increasing the officer's direct holdings to 321,782 shares.

On December 12, 2025, the officer sold 4,874 shares at a weighted average price of $39.73, within a range of $39.37 to $40.12, to cover tax withholding obligations related to the RSU vesting. After these transactions, the officer directly owns 316,908 shares of Series C Common Stock and holds 11,142 restricted stock units, with the remaining units scheduled to vest on December 11, 2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schiller Derek Gordon

(Last) (First) (Middle)

C/O ATLANTA BRAVES HOLDINGS, INC.

755 BATTERY AVENUE SE

(Street)

ATLANTA GA 30339

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Atlanta Braves Holdings, Inc. [ BATRK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Business

3. Date of Earliest Transaction (Month/Day/Year)
12/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Series C Common Stock	12/11/2025		M		11,142	A	$0(1)	321,782	D
Series C Common Stock	12/12/2025		S(2)		4,874	D	$39.73(3)	316,908	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units - BATRK	(4)	12/11/2025		M			11,142	(5)	(5)	Series C Common Stock	11,142	$0	11,142	D

Explanation of Responses:

1. Each restricted stock unit converted into one share of Series C Common Stock.

2. The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.

3. Reflects the weighted average sale price. The range of prices for such transaction is $39.37 to $40.12. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

4. Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.

5. One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026.

	/s/ Kerry T. Wenzel, Attorney-in-Fact	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Atlanta Braves Holdings (BATRA) report in this Form 4?

The EVP, Business of Atlanta Braves Holdings, Inc. reported the conversion of restricted stock units into 11,142 shares of Series C Common Stock on December 11, 2025, followed by the sale of 4,874 shares on December 12, 2025 to cover tax withholding obligations.

How many Atlanta Braves Series C shares did the EVP, Business acquire and sell?

The officer acquired 11,142 shares of Series C Common Stock through restricted stock unit conversion and sold 4,874 shares in a subsequent transaction.

What was the sale price range for the Atlanta Braves (BATRA) shares in this Form 4?

The 4,874 shares of Series C Common Stock were sold at a weighted average price of $39.73, with individual sale prices ranging from $39.37 to $40.12.

How many Series C Common Stock shares does the Atlanta Braves officer own after these transactions?

After the reported transactions, the EVP, Business directly owns 316,908 shares of Atlanta Braves Holdings Series C Common Stock.

What is the vesting schedule of the restricted stock units reported by Atlanta Braves (BATRA)?

Each restricted stock unit represents a right to receive one share of Series C Common Stock. One-third of the award vested on December 11, 2024, another one-third on December 11, 2025, and the remaining restricted stock units are scheduled to vest on December 11, 2026.

How many restricted stock units remain for the Atlanta Braves EVP, Business after this Form 4?

Following the reported conversion, the officer holds 11,142 restricted stock units, each tied to one share of Series C Common Stock.